Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00996827 · ClinicalTrials.gov registry record

Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma

A clinical trial, sponsored by New Mexico Cancer Research Alliance.

Terminated
Registry status
100
Enrollment target

NCT00996827: Clinical Trial study, sponsored by New Mexico Cancer Research Alliance.

NCT00996827 is a clinical trial that was terminated before completion, run by New Mexico Cancer Research Alliance. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00996827 was terminated before completion, sponsored by New Mexico Cancer Research Alliance.

TERMINATED
Registry status
100 participants
Enrollment target

Study Summary

This project seeks to understand differences in the serum vitamin D levels and immune status in cutaneous malignant melanoma patients with different UV exposure histories in New Mexico.

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2009-01
Est. Completion 2013-12

Why NCT00996827 stopped before completion

NCT00996827 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00996827 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00996827 about?

NCT00996827 is a clinical study titled "Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma". This project seeks to understand differences in the serum vitamin D levels and immune status in cutaneous malignant melanoma patients with different UV exposure histories in New Mexico.

What is the current status of trial NCT00996827?

This trial is currently terminated. The enrollment target is 100 participants. The study started on 2009-01. Estimated completion is 2013-12.

Who is sponsoring clinical trial NCT00996827?

This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00996827, the US trial registry maintained by the National Library of Medicine. NCT00996827 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.